Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for mild pediatric obstructive sleep apnoea
ACTRN12607000245493Phase 4Terminated
- Sponsor
- University of New South Wales
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Montelukast with Placebo (2 arms). Primary endpoint: Mixed and obstructive apnoea-hypopnoea index. Started Apr 2007; status: terminated.
02
Drugs
montelukast
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12607000245493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000245493.